BioRestorative Therapies, Inc. (BRTX)
2.14
-0.13
(-5.73%)
USD |
NASDAQ |
Oct 02, 16:00
2.25
+0.11
(+5.14%)
After-Hours: 20:00
BioRestorative Therapies Gross Profit Margin (Quarterly) : -157.8% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -157.8% |
| December 31, 2025 | -178.1% |
| September 30, 2025 | -435.6% |
| June 30, 2025 | 79.72% |
| March 31, 2025 | -118.8% |
| December 31, 2024 | -24.02% |
| September 30, 2024 | 71.53% |
| June 30, 2024 | 39.17% |
| March 31, 2024 | -22.00% |
| December 31, 2023 | -121.2% |
| September 30, 2023 | -37.13% |
| June 30, 2023 | 35.66% |
| March 31, 2023 | -25.88% |
| December 31, 2022 | -2.74K% |
| September 30, 2022 | -107.6% |
| June 30, 2022 | 14.91% |
| March 31, 2022 | -243.8% |
| December 31, 2021 | -912.0% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | -218.9% |
| December 31, 2017 | -68.68% |
| September 30, 2017 | -310.6% |
| June 30, 2017 | -226.0% |
| March 31, 2017 | -818.6% |
| December 31, 2016 | -978.7% |
| September 30, 2016 | -1.21K% |
| June 30, 2016 | -300.6% |
| March 31, 2016 | -585.7% |
| December 31, 2015 | 38.42% |
| September 30, 2015 | -16.65% |
| June 30, 2015 | 16.33% |
| March 31, 2015 | 37.26% |
| December 31, 2014 | -60.53% |
| September 30, 2014 | 43.84% |
| June 30, 2014 | 61.97% |
| March 31, 2014 | -6.30K% |
| December 31, 2013 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 62.51% |
| CareDx, Inc. | 73.37% |
| Natera, Inc. | 63.70% |
| Exagen, Inc. | 61.27% |
| Sera Prognostics, Inc. | -606.7% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -333.4% |
| Return on Assets | -166.5% |
| Return on Invested Capital | -329.9% |
| Profit Margin (Quarterly) | -9.29K% |
| Operating Margin (Quarterly) | -14.59K% |
| Return on Net Operating Assets | -1.21K% |